Re: you won’t see anyone buying this
in response to
by
posted on
Dec 12, 2023 02:41AM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
fuzzyjr - You are not wrong and not right IMO. Because Zenith Capital Corp is officially not listed the share price on the OTCBB market is just somebodies fantasy. The company has stated that they do not support this listing and have also stated that they don't know how it got listed. They have stated that ZCC is a non listed reporting company. If that is the definition of a rudderless, powerless ship bobbing in the sea then they have pretty much nailed the explanation.
As far as I know the only way to value this company/royalty co is by adding up the parts with your own valuations of each part and then taking what ever action you personally feel is the correct thing to do. Your valuation could be way different from others and that's okay because it's what you can justify to you.
I am neither right nor wrong in my assessment of the company either. It's just a crapshoot that was spun out of RVX prior to the results of a phase IIB trial that was supposed to be the catalyst for RVX to be purchased back in 2013. Like the BoM trial though that PIIB trial came short of its target as well. I think that trial was called ASSURE.
If it wasn't for the science in both companies my departure would have been years ago.
Bottom line, you are correct for whatever valuation you place on the parts, there's just no market for the sum of the parts, least at this time.
tada